{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027380","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.113804+00:00","generated_at":"2026-05-16T13:20:28.208684+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"NanoVibronix changes name to ENvue Medical, ticker to FEED effective Dec 12, 2025","bullets":["Effective Dec 12, 2025, NanoVibronix changed name to ENvue Medical, Inc. and ticker symbol from NAOV to FEED on Nasdaq.","CEO Doron Besser said rebranding reflects new strategic direction focused on ENvue feeding-tube placement system.","Company aims to scale hospital utilization and build enteral-feeding ecosystem via internal and external development.","No stockholder action required; CUSIP unchanged; existing shares unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027380","json":"https://secwatch.observer/filing/0001493152-25-027380.json","markdown":"https://secwatch.observer/filing/0001493152-25-027380.md","text":"https://secwatch.observer/filing/0001493152-25-027380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225027380/0001493152-25-027380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225027380/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:20:28.208684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d5c1e69744ac9af833446c3ec211834573c411be","claim":"ENvue Medical, Inc.: The Company changed its name from 'NanoVibronix, Inc.' to 'ENvue Medical, Inc.' via a Certificate of Amendment (effective 2025-12-12).","evidence_excerpt":"On December 8, 2025, the Company filed a Certificate of Amendment to ENvue Medical, Inc. (the “Company”) Certificate of Incorporation (the “Certificate of Amendment”) to change the name of the Company from “NanoVibronix, Inc.” to “ENvue Medical, Inc.” effective as of December 12, 2025 (the “Name Change”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225027380/0001493152-25-027380-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-12-12"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}